메뉴 건너뛰기
Gastroenterology
Volumn 115, Issue 6, 1998, Pages 1606-1607
Anticancer therapy-induced emesis: Existence of an intestinal subtype of the 5-HT3 receptor? [3]
Author keywords

[No Author keywords available]
Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CISPLATIN; ONDANSETRON;
EID: 0031731215     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70058-7     Document Type: Letter
Times cited : (4)
References (4)
  • 1
    • 0029811856 scopus 로고    scopus 로고
    • Serotonin mechanisms in chemotherapy-induced emesis in cancer patients
    • LX Cubeddu Serotonin mechanisms in chemotherapy-induced emesis in cancer patients Oncology 53 suppl 1 1996 18 25
    • (1996) Oncology , vol.53 , Issue.suppl 1 , pp. 18-25
    • Cubeddu, LX1
  • 2
    • 0030582222 scopus 로고    scopus 로고
    • Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy
    • 3) antagonists in the prevention of emesis caused by anticancer therapy Biochem Pharmacol 52 1996 685 692
    • (1996) Biochem Pharmacol , vol.52 , pp. 685-692
    • Karim, F1    Roerig, SC2    Saphier, D3
  • 3
    • 0029095767 scopus 로고
    • Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species
    • 3 receptor: heterogeneity in distribution and function among species Mol Pharmacol 48 1995 407 416
    • (1995) Mol Pharmacol , vol.48 , pp. 407-416
    • Miyake, A1    Mochizuki, S2    Takemoto, Y3
  • 4
    • 0029563275 scopus 로고
    • Cloning and functional expression of a human 5-hydroxytryptamine type 3As receptor subunit
    • s receptor subunit Mol Pharmacol 48 1995 1054 1062
    • (1995) Mol Pharmacol , vol.48 , pp. 1054-1062
    • Belelli, D1    Balcarek, JM2    Hope, AG3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.